A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer.

[1]  L. Påhlman,et al.  Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  T. Kinsella,et al.  Clinical toxicity of peripheral nerve to intraoperative radiotherapy in a canine model. , 1995, International journal of radiation oncology, biology, physics.

[3]  W. Scheithauer,et al.  Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-alpha: an overview of clinical trials. , 1995, European journal of cancer.

[4]  A. Weaver,et al.  Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer , 1995, Cancer.

[5]  P. Goodman,et al.  Adenocarcinoma of the rectum treated by radical external radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[6]  A. Maiolo,et al.  Role of interferon alpha‐2a in the treatment of polycythemia vera , 1995, American journal of hematology.

[7]  D. Huhn,et al.  [Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a]. , 1994, Zeitschrift fur Gastroenterologie.

[8]  K. Okita,et al.  Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. , 1994, Internal medicine.

[9]  W. Enker,et al.  Preoperative 5‐fluorouracil, low‐dose leucovorin, and concurrent radiation therapy for rectal cancer , 1994, Cancer.

[10]  J. Angulo,et al.  Urinoma Formation Secondary to Ureteral Obstruction by Metastatic Squamous Cell Carcinoma of the Appendix. Case Report , 1993, Tumori.

[11]  N. Caporaso,et al.  Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year. , 1993, The Italian journal of gastroenterology.

[12]  P. Tornambe,et al.  Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration. , 1993, Ophthalmology.

[13]  P. Grigsby,et al.  Radiation induced lumbosacral plexopathy in gynecologic tumors: clinical findings and dosimetric analysis. , 1993, International journal of radiation oncology, biology, physics.

[14]  M. Untch,et al.  In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines , 1993, Cancer.

[15]  A. Wong,et al.  Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. , 1993, International journal of radiation oncology, biology, physics.

[16]  S. PérezHerms,et al.  Urinary tract involvement as the first clinical manifestation of adenocarcinoma of the colon , 1993 .

[17]  C. Catton,et al.  Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study. , 1991, International journal of radiation oncology, biology, physics.

[18]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[19]  C. Willett,et al.  Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Balaram,et al.  Lymphocyte subset distribution after radiation therapy for cancer of the uterine cervix. Possible prognostic implications and correlation with disease course , 1991, Cancer.

[21]  T. Kinsella,et al.  Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. , 1991, International journal of radiation oncology, biology, physics.

[22]  C. Willett,et al.  Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma , 1991, Cancer.

[23]  J. K. Martin,et al.  Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  J. Tepper,et al.  Postoperative radiation therapy for incompletely resected colorectal carcinoma. , 1989, International journal of radiation oncology, biology, physics.

[25]  B. Powers,et al.  Ureteral injury following experimental intraoperative radiation. , 1989, International journal of radiation oncology, biology, physics.

[26]  E. Gillette,et al.  Peripheral neuropathies following experimental intraoperative radiation therapy (IORT). , 1989, International journal of radiation oncology, biology, physics.

[27]  R. Souhami,et al.  Recombinant human interferon alpha-2b enhances the radiosensitivity of small cell lung cancer in vitro. , 1989, Anticancer research.

[28]  K. Trott,et al.  Experimental irradiation of the rat ureter: the effects of field size and the presence of contrast medium on incidence and latency of hydronephrosis. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  P. Keng,et al.  Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. , 1987, Cancer research.

[30]  A. Dritschilo,et al.  The combined use of interferon and radiotherapy in cancer management. , 1986, Seminars in oncology.

[31]  R. Gelber,et al.  Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery Radiation Therapy Oncology Group study (76–16) , 1985, American journal of clinical oncology.

[32]  J. Earle,et al.  Differential diagnosis between radiation and tumor plexopathy of the pelvis , 1985, Neurology.

[33]  P. Schein,et al.  A phase II trial of high‐dose intravenous interferon alpha‐2 in advanced colorectal cancer , 1984, Cancer.

[34]  M. Namba,et al.  In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells , 1984, Cancer.

[35]  S. Rosenberg,et al.  Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): clinical and experimental studies. , 1984, International journal of radiation oncology, biology, physics.

[36]  J. Tepper,et al.  Complications of intraoperative radiation therapy. , 1984, International journal of radiation oncology, biology, physics.

[37]  H. Strander,et al.  Treatment of patients with disseminated colorectal cancer with recombinant human alpha2‐interferon. Studies on the immune system , 1984, International journal of cancer.

[38]  B. Petrini,et al.  Distribution of lymphocyte subsets following radiation therapy directed to different body regions. , 1983, Clinical oncology.

[39]  M. O’connell,et al.  A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinoma. , 1982, International journal of radiation oncology, biology, physics.

[40]  A. Starreveld,et al.  Lumbo-Sacral Radiculopathy Induced by Radiation , 1977, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[41]  D. Janerich.  Sex ratio and season of birth. , 1971, Lancet.

[42]  C. Moertel,et al.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.

[43]  C. C. Wang,et al.  The role of radiation therapy in the management of carcinoma of the sigmoid, rectosigmoid, and rectum. , 1962, Radiology.

[44]  M. Mohiuddin,et al.  High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. , 1994, International journal of radiation oncology, biology, physics.

[45]  S. Cha,et al.  Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  S. Lippman,et al.  Retinoic acid and interferon combination studies in human cancer. , 1993, European journal of cancer.

[47]  M. Mohiuddin,et al.  High-dose preoperative radiation for cancer of the rectum: impact of radiation dose on patterns of failure and survival. , 1993, International journal of radiation oncology, biology, physics.

[48]  T. Delaney,et al.  Lumbosacral plexopathy secondary to hyperfractionated radiation therapy: A case presentation and literature review , 1993 .

[49]  S. McDonald,et al.  Combined Betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer. , 1993, International journal of radiation oncology, biology, physics.

[50]  J. Overgaard,et al.  A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. , 1993, Acta oncologica.

[51]  J. Horiot,et al.  Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. , 1993, European journal of cancer.

[52]  K. Cantell,et al.  Interferon combined with irradiation in the treatment of operable head and neck carcinoma. A pilot study. , 1992, Acta oncologica.

[53]  K. Cantell,et al.  Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer. , 1992, International journal of radiation oncology, biology, physics.

[54]  K. Bland,et al.  Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery. , 1987, Annals of surgery.

[55]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.